In this episode of the PrimeRx Podcast, David Kirkus breaks down one of the most pressing challenges facing today’s pharmacy industry—pharmaceutical tariffs. With increasing trade tensions and new policies taking shape, pharmacies across the country are bracing for the potential ripple effects on drug pricing, supply chain stability, and patient access.
David unpacks how tariffs on imported Active Pharmaceutical Ingredients (APIs) and finished medications—especially from countries like China and India—are creating vulnerabilities in a system already strained by global disruptions. Listeners will gain a practical understanding of how these policies could impact everything from acquisition costs and pricing models to patient outcomes and inventory reliability.
The conversation also highlights regulatory and legislative responses, and what pharmacies can do now to prepare. From strategic sourcing to investing in automation and domestic partnerships, David offers clear-eyed guidance for navigating today’s trade turbulence.
